This is a message for individuals suffering from diabetic, pressure, or venous stasis ulcers.  Ogenix Corporation, a Cleveland medical device company, is looking for volunteers to participate in a 10-week product trial of its FDA-approved device for treatment of diabetic, pressure, and venous stasis ulcers.  This prescription device has shown promising results in previous product trials with these types of wounds.  The trials will be conducted in conjunction with the participants’ physicians.  Ogenix will cover the cost of the devices for those eligible for the study.

If you would like more information on this product, or would like to determine if you are eligible to participate in this study, please contact Ogenix Corporation at 216-378-4281.